KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Work In Process (2018 - 2022)

TherapeuticsMD filings provide 5 years of Work In Process readings, the most recent being $218000.0 for Q3 2022.

  • On a quarterly basis, Work In Process fell 68.31% to $218000.0 in Q3 2022 year-over-year; TTM through Sep 2022 was $218000.0, a 68.31% decrease, with the full-year FY2021 number at $1.6 million, up 83.46% from a year prior.
  • Work In Process hit $218000.0 in Q3 2022 for TherapeuticsMD, down from $1.7 million in the prior quarter.
  • In the past five years, Work In Process ranged from a high of $1.7 million in Q2 2022 to a low of $83911.0 in Q3 2018.
  • Median Work In Process over the past 5 years was $808694.0 (2019), compared with a mean of $849310.4.
  • Biggest five-year swings in Work In Process: soared 1098.38% in 2019 and later tumbled 68.31% in 2022.
  • TherapeuticsMD's Work In Process stood at $339312.0 in 2018, then soared by 248.37% to $1.2 million in 2019, then dropped by 24.28% to $895000.0 in 2020, then soared by 83.46% to $1.6 million in 2021, then tumbled by 86.72% to $218000.0 in 2022.
  • The last three reported values for Work In Process were $218000.0 (Q3 2022), $1.7 million (Q2 2022), and $1.2 million (Q1 2022) per Business Quant data.